Chulalongkorn University
Pornanong Aramwit, Pharm.D., Ph.D
The objectives of this study are to evaluate efficacy and safety of artificial saliva containing cumin and ginger extract in head and neck cancer patients with xerostomia.
Xerostomia
Artificial saliva containing cumin and ginger extract
Placebo
NA
There are 52 patients in this study. They are divided into 2 groups which are artificial saliva containing cumin and ginger extract group (test group) 26 patients and placebo group 26 patients. The patients spray the sample into the mouth 3 times/day for 14 day. Amount of saliva, pH of saliva, xerostomia questionnaires, WHO Oral Mucositis Grading Scale, quality of life, adverse events, and satisfaction were assessed.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 52 participants |
Masking : | QUADRUPLE |
Primary Purpose : | TREATMENT |
Official Title : | Efficacy and Safety of Artificial Saliva Containing Cumin and Ginger Extract in Head and Neck Cancer Patients With Xerostomia |
Actual Study Start Date : | 2024-07-01 |
Estimated Primary Completion Date : | 2025-05-30 |
Estimated Study Completion Date : | 2025-06-30 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
No Location Found